Finance

Lists
2633:HKG
Jacobson Pharma Corporation Ltd
HK$0,96
0,00%
(0,00) 1D
16 Okt., 16:00:00 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2633...
Open
HK$0,97
High
HK$0,97
Low
HK$0,96
Mkt. cap
1,92 mjd
Avg. vol.
341,42 k
Volume
16,00 k
Dividend
9,38%
Quarterly dividend
HK$0,02
Ex-dividend date
07 Sep. 2026
P/E ratio
6,36
52-wk high
HK$1,49
52-wk low
HK$0,94
EPS
HK$0,15
Shares outstanding
2,00 mjd
No. of employees
2 k
Open
HK$0,97
High
HK$0,97
Low
HK$0,96
Mkt. cap
1,92 mjd
Avg. vol.
341,42 k
Volume
16,00 k
Dividend
9,38%
Quarterly dividend
HK$0,02
Ex-dividend date
07 Sep. 2026
P/E ratio
6,36
52-wk high
HK$1,49
52-wk low
HK$0,94
EPS
HK$0,15
Shares outstanding
2,00 mjd
No. of employees
2 k
News stories
From web sources and news partners
About Jacobson Pharma Corporation Ltd
CEO-
Employees1,77 k
Founded2016
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in HKD
Loading Previous Earnings...
Revenue
Net income
All values in HKD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
383,28 m
383,28 m
401,46 m
401,46 m
Cost of goods sold
214,38 m
214,38 m
231,40 m
231,40 m
Cost of revenue
214,38 m
214,38 m
231,40 m
231,40 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
84,50 m
84,50 m
77,87 m
77,87 m
Operating expense
76,94 m
76,94 m
68,14 m
68,14 m
Total operating expenses
291,32 m
291,32 m
299,54 m
299,54 m
Operating income
91,96 m
91,96 m
101,91 m
101,91 m
Other non operating income
-
-
-
-
EBT including unusual items
86,77 m
86,77 m
94,55 m
94,55 m
EBT excluding unusual items
89,21 m
89,21 m
95,96 m
95,96 m
Income tax expense
15,75 m
15,75 m
14,76 m
14,76 m
Effective tax rate
18,15%
18,15%
15,61%
15,61%
Other operating expenses
-7,55 m
-7,55 m
-9,73 m
-9,73 m
Net income
71,02 m
71,02 m
79,79 m
79,79 m
Net profit margin
18,53%
18,53%
19,88%
19,88%
Earnings per share
-
-
-
-
Interest and investment income
2,25 m
2,25 m
1,91 m
1,91 m
Interest expense
-6,46 m
-6,46 m
-8,90 m
-8,90 m
Net interest expenses
-4,20 m
-4,20 m
-6,99 m
-6,99 m
Depreciation and amortization charges
-
-
-
-
EBITDA
122,05 m
122,05 m
131,17 m
131,17 m
Gain or loss from assets sale
-
-
87,50 k
87,50 k
AI content may include mistakes. Learn more
Google-programme